Indian Patent Office Delivers Major Blow to Affordable Pneumonia Vaccine Hopes

Press releaseIndian Patent Office Delivers Major Blow to Affordable Pneumonia Vaccine HopesAugust 22, 2017Hopes for improved access to an affordable pneumococcal conjugate vaccine (PCV) that protects both children and adults from pneumonia was dealt a major blow after the Indian patent office granted a patent to the U.S. pharmaceutical corporation Pfizer.

Source: MSF News - August 22, 2017 Category: International Medicine & Public Health Authors: Brienne Prusak Source Type: news